期刊文献+

内脂素与非酒精性脂肪肝肝纤维化及胰岛素抵抗的关系 被引量:1

Association of serum vaspin with liver fibrosis of nonalcoholic fatty liver disease and insulin resistance
下载PDF
导出
摘要 目的研究内脂素(vaspin)水平与非酒精性脂肪肝(NAFLD)患者肝纤维化指标及胰岛素抵抗指数(IRI)的关系。方法采用酶联免疫吸附检测(ELASA)法对NAFLD组和对照组的内脂素及Ⅲ型前胶原(PCⅢ)、Ⅳ型胶原(PCⅣ)、透明质酸(HA)、层黏连蛋白(LN)水平进行检测,采用稳态模型胰岛素抵抗指数(HOMA-IRI)评估胰岛素抵抗。结果NAFLD组内脂素显著低于对照组(0.76±0.45)g/L vs(1.31±0.82)g/L;肝纤维化指标PCⅢ、HA、PCⅣ、LN及HOMA-IRI显著高于对照组(136.42±36.32)μg/L vs(98.16±23.71)μg/L,(95.33±37.63)μg/Lvs(69.26±29.16)μg/L,(75.52±32.56)μg/L vs(57.64±16.21)μg/L,(127.27±31.53)μg/L vs(102.43±27.14)μg/L,3.19±1.23 vs 1.84±0.71(均P<0.05);HOMA-IRI与PCⅢ、PCⅣ、HA和LN呈显著正相关(均P<0.05),内脂素水平与WHR、BMI、FBG、TG、FINS、HOMA-IRI、PCⅢ、PCⅣ、HA和LN呈显著负相关(P<0.01或<0.05)。结论NAFLD患者血清内脂素水平降低,内脂素的表达在NAFLD患者肝纤维化与胰岛素抵抗进程中可能起抑制作用。 Objective To investigate the relationship of the scale of serum vaspin to liver fibrosis indexes of nonalcoholic fatty liver disease(NAFLD) and insulin resistance index(IRI). Methods Enzyme linked immunosorbent assay(ELASA) was used to measure the serum levels of vaspin,type Ⅲ precollagen(PCⅢ ),type Ⅳ collagen(PCⅣ), hyaluronic acid(HA) and laminin(LN) between NAFLD group and control group. IRI was calculated with Homeostasis Model Assessment. Results The level of vaspin significantly decreased in NAFLD group compared with that of control group (0.76±0.45) g/L vs (1.31±0.82) g/L( P 〈0.05) ,while HOMA-IRI and liver fibrosis indexes PCⅢ , HA,PC Ⅳ ,LN significantly increased in NAFLD group in contrast to those of control group, HOMA-IRI 3.19 ± 1.23 vs 1.84 ± 0.71,PCⅢ (136.42±36.32) μg/L vs (98.16±23.71) μg/L, HA (95.33±37.63) μg/L vs (69.26±29.16) μg/L, PCIV (75.52±32.56) μg/L vs (57.64±16.21) μg/L,LN (127.27±31.53) μg/L vs (102.43±27.14) μg/L( P 0.05). There was positive correlation between HOMA-IRI and serum PCⅢ ,PCⅣ, HA,LN levels(all P 〈0.05) ,while negative correlation was evident among vaspin level and W HR, BMI, FBG, TG, FINS, HOMA-IRI, PC Ⅲ, PC Ⅳ, H A and LN,compared with those control group( P 〈0.01 or 〈0.05). Conclusion The level of vaspin significantly decreases in NAFLD patients. The expression of vaspin may have significant negative influence on the process of liver fibrosis and insulin resistance in NAFLD patients.
出处 《临床荟萃》 CAS 2009年第10期852-855,共4页 Clinical Focus
关键词 脂肪肝 肽类激素 胰岛素抗体 肝硬化 fatty liver peptide hormones insulin antibodies liver cirrhosis
  • 相关文献

参考文献7

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志,2003,11(2):71-71. 被引量:1368
  • 2王战建,王振贤,王书畅.不同血糖水平人群脂联素血清水平与胰岛素抵抗的关系[J].临床荟萃,2007,22(1):17-19. 被引量:5
  • 3Hida K,Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor : unique insulin-sensitizing adipocytokine in obesity[J]. Proc Natl Acad Sci USA,2005,102 (30) : 10610-10615.
  • 4Kloting N,Berndt J,Kralisch S,et al. Vaspin gene expression in human adipose tissue; association with obesity and type 2 diabetes[J]. Bioehem Biophys Res Commun, 2006,339 (1) ; 430- 436.
  • 5Youn BS, Kloting N, Kratzsch J, et al. Serum vaspin concentrations in human obesity and type 2 diabetes [ J]. Diabetes,2008,57(2) :372-377.
  • 6Li Q, Chen R, Moriya J, et al. Visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity[J]. J Int Med Res, 2008,36 (4): 625-629.
  • 7Wada J. Vaspin: a novel serpin with insulin-sensitizing effects [J]. Expert Opin Investig Drugs, 2008,17 (3) : 327-333.

二级参考文献7

  • 1Hotta K,Funahashi T,Bodkin NL,et al.Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys[J].Diabetes,2001,50(5):1126-1133.
  • 2Kubota N,Terauchi Y,Yamauchi T,et al.Disruption of adiponectin causes insulin resistance and neointimal formation[J].J Biol Chem,2002,227(29):25863-25866.
  • 3Maeda N,Shimomura I,Kishida K,et al.Diet-induced insulin resistance in mice lacking adiponectin/ACR30[J].Nat Med,2002,8(7):731-737.
  • 4Yamauchi T,Kamon J,Waki H,et al.Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis[J].J Biol Chem,2003,278(4):2461-2468.
  • 5Weyer C,Funahashi T,Tanaka S,et al.Hypoadiponectin in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia[J].J Clin Endocrinol Metab,2001,86(5):1930-1935.
  • 6Yamauchi T,Kamon J,Waki H,et al.The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7(8):941-946.
  • 7Fruebis J,Tsao TS,Javorschi S,et al.Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice[J].Proc Natl Acad Sci USA,2001,98 (4):2005-2010.

共引文献1371

同被引文献11

  • 1Auguet T, Quintero Y, Riesco D, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women[J]. BMC Med Genet, 2011, 28(12) : 60 - 67.
  • 2Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue - derived serine pretease inhibitor: A unique insulin - sensitizing adipocyto- kine in obesity [ J ]. Proc Nstl Acad Sci USA, 2005, 102 ( 6 ) : 10610 - 10615.
  • 3Bltiher M. Vaspin in obesity and diabetes: pathophysiologieal and elinieal significance[ J]. Endocrine, 2012, 41 (2) : 176 - 182.
  • 4Kadlou NP, Gkontopoulos A, Kapelouzou A, et al. Serum levels of vaspin and visfatin in patients with coronary artery disease - Kozani study[J]. Clin Chim Acta, 2010, 412(1 -2) : 48 -52.
  • 5Kukla M, Zwirska - Korczala K, Gabriel A, et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C [ J]. J Viral Hep- at, 2010, 17(9) : 661 -667.
  • 6Senolt L, Polanska M, Filkova M, et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis[J]. Ann Rheum Dis, 2010, 69(7) : 1410 - 1411.
  • 7Aktas B, Yilmaz Y, Eren F, et al. Serum levels of vaspin, obesta- tin, and apelin - 36 in patients with nonalcoholic fatty liver disease [J]. Metabolism, 2011,60(4): 544-549.
  • 8胡伟.类风湿关节炎患者血清Vaspin变化及相关因素的分析[J].中国医药导报,2011,8(18):30-32. 被引量:4
  • 9陈燕,李伶,杨刚毅,李钶,李生兵,董静.糖代谢改善对2型糖尿病患者血浆vaspin水平的影响[J].中国糖尿病杂志,2012,20(9):650-653. 被引量:7
  • 10黄仕鹏,刘建英.vaspin与肥胖及2型糖尿病相关性研究进展[J].中国糖尿病杂志,2012,20(9):713-715. 被引量:6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部